LY518674

Cat. No.: 0225LY-0908

Appearance: Viscous

Purity: ≥98%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: LY518674 is a selective and potent PPARα agonist (EC50: 42 nM for the human subtype) used to treat atherosclerosis by increasing HDL-C and lowering triglyceride levels.

Synonym: LY-674; 425671-29-0; LY518674; LY-674; Ly 518674; 2-Methyl-2-[4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl]phenoxy]propanoic acid; 2-Methyl-2-(4-{3-(1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propyl}phenoxy)propanoic acid; Propanoic acid, 2-(4-(3-(2,5-dihydro-1-((4-methylphenyl)methyl)-5-oxo-1H-1,2,4-triazol-3-yl)propyl)phenoxy)-2-methyl-; 2-methyl-2-(4-(3-(1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propyl)phenoxy)propanoic acid; 2-methyl-2-[4-[3-[1-[(4-methylphenyl)methyl]-5-oxo-2H-1,2,4-triazol-3-yl]propyl]phenoxy]propanoic acid; 2-methyl-2-[4-[3-[1-[(4-methylphenyl)methyl]-5-oxo-4H-1,2,4-triazol-3-yl]propyl]phenoxy]propanoic acid; 2-methyl-2-[4-[3-[2-[(4-methylphenyl)methyl]-3-oxo-1H-1,2,4-triazol-5-yl]propyl]phenoxy]propanoic acid

CAS No.: 425671-29-0

Compound CID: 135449333

Formula: C₂₃H₂₇N₃O₄

Formula Weight: 409.48